Login / Signup

Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6.

William David StrainOfir FrenkelMartin A JamesLawrence Alan LeiterSøren RasmussenPeter M RothwellMaria Sejersten RipaThomas Clement TruelsenMansoor Husain
Published in: Stroke (2022)
gov; Unique identifier: NCT01720446 and NCT02692716.
Keyphrases
  • type diabetes
  • double blind
  • open label
  • atrial fibrillation
  • placebo controlled
  • phase iii
  • glycemic control
  • phase ii
  • cardiovascular disease
  • clinical trial
  • cerebral ischemia